Silverback Asset Management »

Travere Therapeutics shares owned by Silverback Asset Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Silverback Asset Management from 13F filings

Historical chart of Silverback Asset Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Silverback Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Silverback Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $358M 40k 8940.00

More positions owned by Silverback Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cyberark Software Note 11/1 (Principal)
Dish Network Corporation Note 3.375% 8/1 (Principal)
Fubotv Note 3.250% 2/1 (Principal)
Infinera Corp Note 3.750% 8/0 (Principal)
Nova Note 10/1 (Principal)
Ivanhoe Mines Note 2.500% 04/15/26 (Principal)
Lumentum Hldgs Note 0.500%12/1 (Principal)
Varonis Sys Note 1.250% 8/1 (Principal)
Wayfair Note 1.000% 8/1 (Principal)
Digitalocean Hldgs Note 12/0 (Principal)
Liveperson Note 12/1 (Principal)
Bandwidth Note 0.250% 3/0 (Principal)
Infinera Corp Note 2.500% 3/0 (Principal)
Ford Mtr Co Del Note 3/1 (Principal)

View all positions for Silverback Asset Management

Top funds holding Travere Therapeutics

Vanguard Group
Deutsche Bank Aktiengesellschaft
Kynam Capital Management
Jacobs Levy Equity Management
D. E. Shaw & Co
Bank of America Corporation
Goldman Sachs Group
Millennium Management
Emerald Advisers
Avidity Partners Management
Emerald Mutual Fund Advisers, Trust
Schonfeld Strategic Advisors
Barclays
Healthcare Of Ontario Pension Plan Trust Fund
Two Sigma Advisers

View all funds holding Travere Therapeutics